Pediatrix Medical beats Q2 revenue estimates, reaffirms 2026 adjusted EBITDA outlook
Pediatrix Medical beats Q2 revenue estimates, reaffirms 2026 adjusted EBITDA outlook
Overview
US physician services provider's Q2 revenue rose 4%, beating analyst expectations
Q2 adjusted EBITDA slightly beat analyst expectations
Adjusted EPS for Q2 rose to $0.63 from $0.53 a year earlier
Outlook
Pediatrix reaffirms 2026 full-year Adjusted EBITDA outlook at $280 mln to $300 mln
Result Drivers
RECENT ACQUISITIONS - Co said revenue growth was driven by recent acquisitions, partially offset by practice dispositions
REIMBURSEMENT FACTORS - Improved cash collections, favorable payor mix and higher patient acuity, mainly in neonatology, boosted same-unit revenue from net reimbursement-related factors
DECLINING PATIENT VOLUMES - Same-unit revenue attributable to patient volume decreased by 2.1% in Q2, with hospital-based and neonatology services seeing declines
Company press release: ID:nBw9x2TZ5a
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Beat | $487.78 mln | $478.45 mln (7 Analysts) |
Q2 Net Income |
| $39.84 mln |
|
Q2 Adjusted EBITDA | Slight Beat* | $76.43 mln | $75.71 mln (7 Analysts) |
Q2 Income from operations |
| $56.92 mln |
|
Q2 Operating Expenses |
| $430.86 mln |
|
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Pediatrix Medical Group Inc is $26.00, about 1% below its August 3 closing price of $26.25
The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 10 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)